| |
| |
|
| Insider
Information: |
Foletta Mark G |
| Relationship: |
EVP & Chief Financial ... |
| City: |
San Diego |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
5 |
|
| Direct
Shares |
110,512 |
|
|
Indirect Shares
|
59,092 |
|
|
| Direct
Value |
$1,180,998 |
|
|
|
Indirect Value
|
$7,507,639 |
|
|
| Total
Shares |
169,604 |
|
|
| Total
Value |
$8,688,636 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
1
|
|
Stock
price went up :
|
1
|
1
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
1.0
|
| Percentage
Gain/Loss : |
 8.1%
|
13.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Amylin Pharmaceuticals Inc |
AMLN |
SVP, Chief Financial O... |
2012-08-08 |
0 |
2012-08-08 |
0 |
Premium* |
|
|
DexCom Inc |
DXCM |
Director |
2023-05-18 |
3,306 |
2023-05-18 |
59,092 |
Premium* |
|
|
Regulus Therapeutics Inc. |
RGLS |
Director |
2017-12-04 |
81,910 |
2015-08-13 |
0 |
Premium* |
|
|
AMN Healthcare Services Inc |
AHS |
Director |
2024-04-19 |
10,254 |
2016-04-20 |
0 |
Premium* |
|
|
Forte Biosciences Inc |
FBRX |
EVP & Chief Financial ... |
2019-05-28 |
15,042 |
2017-04-19 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
141 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial OfficerSV |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$370,531 |
I/I |
(11,953) |
0 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial OfficerSV |
• – – |
2012-08-08 |
4 |
D |
$31.00 |
$2,005,762 |
D/D |
(64,702) |
0 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2019-05-30 |
4 |
D |
$0.00 |
$0 |
D/D |
(4,052) |
0 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-05-21 |
4 |
D |
$0.00 |
$0 |
D/D |
(3,055) |
0 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-05-20 |
4 |
D |
$0.00 |
$0 |
D/D |
(895) |
0 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2022-05-19 |
4 |
D |
$0.00 |
$0 |
D/D |
(1,054) |
0 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2020-05-22 |
4 |
A |
$0.00 |
$1 |
D/D |
895 |
895 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2021-05-21 |
4 |
A |
$0.00 |
$1 |
D/D |
1,054 |
1,054 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2022-05-20 |
4 |
A |
$0.00 |
$1 |
D/D |
1,122 |
1,122 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2019-05-31 |
4 |
A |
$0.00 |
$3 |
D/D |
3,055 |
3,055 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2023-05-18 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,488 |
3,306 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
Sr VP Finance & CFO |
• – – |
2009-03-04 |
4 |
A |
$0.00 |
$0 |
I/I |
2,550 |
3,455 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2017-11-27 |
4 |
S |
$47.03 |
$117,575 |
D/D |
(2,500) |
3,525 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2016-12-15 |
4 |
S |
$37.81 |
$68,058 |
D/D |
(1,800) |
3,732 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2018-06-01 |
4/A |
A |
$0.00 |
$4 |
D/D |
4,052 |
4,052 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP Chief Financial Officer |
• – – |
2010-02-03 |
4 |
A |
$0.00 |
$0 |
I/I |
1,360 |
4,815 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
• – – |
2017-04-19 |
4 |
B |
$10.00 |
$50,000 |
D/D |
5,000 |
5,000 |
2.74 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2016-04-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,532 |
5,532 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2017-06-13 |
4 |
S |
$36.71 |
$55,058 |
D/D |
(1,500) |
6,025 |
0 |
- |
|
| AMLN |
Amylin Pharmaceuticals In... |
SVP, Chief Financial Officer |
• – – |
2011-03-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,630 |
6,445 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2018-04-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,365 |
6,890 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2014-11-17 |
4 |
A |
$0.00 |
$7 |
D/D |
7,322 |
7,322 |
0 |
- |
|
| FBRX |
Forte Biosciences Inc |
EVP & Chief Financial Officer |
• – – |
2017-12-08 |
4 |
A |
$8.50 |
$21,250 |
D/D |
2,500 |
7,500 |
0 |
- |
|
| AHS |
AMN Healthcare Services I... |
Director |
– • – |
2017-04-19 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,793 |
7,525 |
0 |
- |
|
| DXCM |
DexCom Inc |
Director |
– • – |
2023-05-18 |
4 |
A |
$0.00 |
$3 |
D/D |
3,306 |
7,794 |
0 |
- |
|
141 Records found
|
|
Page 1 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
